Paul Giannasca

60 year

Health Technology

Consumer Services

Profile

Paul Giannasca worked as a Scientist at OraVax, Inc. and as Vice President-Development at Acambis Plc and Genocea Biosciences, Inc. He obtained an undergraduate degree from Fairleigh Dickinson University and a doctorate degree from the University of Massachusetts.

Former positions of Paul Giannasca

Companies	Position	End
OraVax, Inc. OraVax, Inc. BiotechnologyHealth Technology Part of Sanofi, OraVax, Inc. is a company that has a slick name that taps into the words 'oral' and 'vaccine' in a subtle way. The company is based in Cambridge, MA. The company is a possible oral health brand, medical licensing service, app, or chemicals company. OraVax was acquired by Acambis Plc, part of Sanofi from September 22, 2008 on May 11, 1999 for $17.79 million.	Corporate Officer/Principal	-
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	-
Acambis Plc Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.	Corporate Officer/Principal	-

See the detail of Paul Giannasca's experience

Training of Paul Giannasca

Fairleigh Dickinson University	Undergraduate Degree
University of Massachusetts	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies